A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. “We tested the antibody in various ways, including on... Read more
VaxHit could be applied to 90 percent of all known cancers In a breakthrough development, the Israeli company Vaxil BioTherapeutics has formulated a therapeutic cancer vaccine, now in clinic... Read more